Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 19Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neutropenia 1Hematologic Neoplasms 1Fever 1

Interventions

Sunitinib 16exemestane 11Afatinib 11palbociclib 10Rituximab 10Bevacizumab 10Erlotinib Hydrochloride 9Leuprolide 8Radiotherapy 7Drug Therapy 7Axitinib 7avelumab 6Letrozole 6Capecitabine 6Blood Specimen Collection 6enzalutamide 5Trastuzumab 5Surveys and Questionnaires 5Standard of Care 5Docetaxel 5Aromatase Inhibitors 5lorlatinib 4Specimen Handling 4Radiation 4Mammography 4Crizotinib 4Anastrozole 4Abiraterone Acetate 4temsirolimus 3talazoparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Has results × Itraconazole × Clear all
NCT01021683 2013-08-12

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Janssen Korea, Ltd., Korea

Completed
203 enrolled 14 charts
Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡